Xerostomia

Periodontology 2000

Volumn 48, Issue 1, 2008, Pages 85-91

  Eveson, John W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

SALIVA SUBSTITUTE;

FEMALE; HUMAN; MALE; MOUTH HYGIENE; REVIEW; XEROSTOMIA;

FEMALE; HUMANS; MALE; ORAL HYGIENE; SALIVA, ARTIFICIAL; XEROSTOMIA;

EID: 49349097186     PISSN: 09066713     EISSN: 16000757     Source Type: Journal    
DOI: 10.1111/j.1600-0757.2008.00263.x     Document Type: Review

References (57)

1. Anderson DJ, Hector MP. Periodontal mechanoreceptors and parotid secretion in animals and man. J Dent Res 1987 : 66 : 518 523.
2. Andersson G, Johansson G, Attström R, Edwardsson S, Glantz PO, Larsson K. Comparison of the effect of the linseed extract Salinum and a methyl cellulose preparation on the symptoms of dry mouth. Gerodontology 1995 : 12 : 12 17.
3. Bagheri H, Schmitt L, Berlan M, Montastruc JL. A comparative study of the effects of yohimbine and anetholtrithione on salivary secretion in depressed patients treated with psychotropic drugs. Eur J Clin Pharmacol 1997 : 52 : 339 342.
4. Bialek EJ, Jakubowski W, Zajkowski P, Szopinski KT, Osmolski A. US of the major salivary glands: anatomy and spatial relationships, pathologic conditions, and pitfalls. Radiographics 2006 : 26 : 745 763.
5. Blom M, Kopp S, Lundeberg T. Prognostic value of the pilocarpine test to identify patients who may obtain long-term relief from xerostomia by acupuncture treatment. Arch Otolaryngol Head Neck Surg 1999 : 125 : 561 566.
6. Blom M, Lundeberg T. Long-term follow-up of patients treated with acupuncture for xerostomia and the influence of additional treatment. Oral Dis 2000 : 6 : 15 24.
7. Carbone A, Gloghini A, Ferlito A. Pathological features of lymphoid proliferations of the salivary glands: lymphoepithelial sialadenitis versus low-grade B-cell lymphoma of the malt type. Ann Otol Rhinol Laryngol 2000 : 109 : 1170 1175.
8. Cawson RA, Gleeson MJ, Eveson JW. Pathology and Surgery of the Salivary Glands. Isis Medical Media, 1997 : 238.
9. Chambers MS, Mellberg JR, Keene HJ, Bouwsma OJ, Garden AS, Sipos T, Fleming TJ. Clinical evaluation of the intraoral fluoride releasing system in radiation-induced xerostomic subjects. Part 1: fluorides. Oral Oncol 2006 : 42 : 934 945.
10. Chambers MS, Mellberg JR, Keene HJ, Bouwsma OJ, Garden AS, Sipos T, Fleming TJ. Clinical evaluation of the intraoral fluoride releasing system in radiation-induced xerostomic subjects. Part 2: phase I study. Oral Oncol 2006 : 42 : 946 953.
11. Chambers MS, Posner M, Jones CU, Biel MA, Hodge KM, Vitti R, Armstrong I, Yen C, Weber RS. Cevimeline for the treatment of postirradiation xerostomia in patients with head and neck cancer. Int J Radiat Oncol Biol Phys 2007 : 68 : 1102 1109.
12. Chambers MS, Jones CU, Biel MA, Weber RS, Hodge KM, Chen Y, Holland JM, Ship JA, Vitti R, Armstrong I, Garden AS, Haddad R. Open-label, long-term safety study of cevimeline in the treatment of postirradiation xerostomia. Int J Radiat Oncol Biol Phys 2007 : 69 : 1369 1376.
13. Chaudhry AP, Cutler LS, Yamane GM, Satchidanand S, Labay G, Sunderraj M. Light and ultrastructural features of lymphoepithelial lesions of the salivary glands in Mikulicz's disease. J Pathol 1986 : 148 : 239 250.
14. Corcoran RA, Stovell AG, Urquhart D, Chui T, Richardson M. Evaluation of a combined polymer system for use in relieving the symptoms of xerostomia. J Clin Dent 2006 : 17 : 34 38.
15. Daniels TE, Whitcher JP. Association of patterns of labial salivary gland inflammation with keratoconjunctivitis sicca. Analysis of 618 patients with suspected Sjögren's syndrome. Arthritis Rheum 1994 : 37 : 869 877.
16. Davies AN. A comparison of artificial saliva and chewing gum in the management of xerostomia in patients with advanced cancer. Palliat Med 2000 : 14 : 197 203.
17. Dawidson I, Angmar-Månsson B, Blom M, Theodorsson E, Lundeberg T. Sensory stimulation (acupuncture) increases the release of vasoactive intestinal polypeptide in the saliva of xerostomia sufferers. Neuropeptides 1998 : 32 : 543 548.
18. Epstein JB, Emerton S, Le ND, Stevenson-Moore P. A double-blind crossover trial of Oral Balance gel and Biotene toothpaste versus placebo in patients with xerostomia following radiation therapy. Oral Oncol 1999 : 35 : 132 137.
19. Ferguson MM. Pilocarpine and other cholinergic drugs in the management of salivary gland dysfunction. Oral Surg Oral Med Oral Pathol 1993 : 75 : 186 191.
20. Fife RS, Chase WF, Dore RK, Wiesenhutter CW, Lockhart PB, Tindall E, Suen JY. Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome: a randomized trial. Arch Intern Med 2002 : 162 : 1293 1300.
21. Gibson J, Halliday JA, Ewert K, Robertson S. A controlled release pilocarpine buccal insert in the treatment of Sjögren's syndrome. Br Dent J 2007 : 202 : E17.
22. Grisius MM. Salivary gland dysfunction: a review of systemic therapies. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001 : 92 : 156 162.
23. Hamada T, Nakane T, Kimura T, Arisawa K, Yoneda K, Yamamoto T, Osaki T. Treatment of xerostomia with the bile secretion-stimulating drug anethole trithione: a clinical trial. Am J Med Sci 1999 : 318 : 146 151.
24. Harris NL. Lymphoid proliferations of the salivary glands. Am J Clin Pathol 1999 : 111 (Suppl. 1 S94 S103.
25. Jellema AP, Langendijk H, Bergenhenegouwen L, van der Reijden W, Leemans R, Smeele L, Slotman BJ. The efficacy of xialine in patients with xerostomia resulting from radiotherapy for head and neck cancer: a pilot-study. Radiother Oncol 2001 : 59 : 157 160.
26. Jones JM, Watkins CA, Hand JS, Warren JJ, Cowen HJ. Comparison of three salivary flow rate assessment methods in an elderly population. Community Dent Oral Epidemiol 2000 : 28 : 177 184.
27. Joyston-Bechal S, Kidd EA. New formulation for 'Luborant' saliva substitute. Br Dent J 1991 : 170 : 174.
28. Kalk WW, Vissink A, Spijkervet FK, Bootsma H, Kallenberg CG, Roodenburg JL. Parotid sialography for diagnosing Sjögren syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002 : 94 : 131 137.
29. Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjögren syndrome. Arch Intern Med 2004 : 164 : 1275 1284.
30. Lee A, Guest S, Essick G. Thermally evoked parotid salivation. Physiol Behav 2006 : 87 : 757 764.
31. LeVeque FG, Montgomery M, Potter D, Zimmer MB, Rieke JW, Steiger BW, Gallagher SC, Muscoplat CC. A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients. J Clin Oncol 1993 : 11 : 1124 1131.
32. Lormeau C, Falgarone G, Roulot D, Boissier MC. Rheumatologic manifestations of chronic hepatitis C infection. Joint Bone Spine 2006 : 73 : 633 638.
33. Mavragani CP, Moutsopoulos NM, Moutsopoulos HM. The management of Sjögren's syndrome. Nat Clin Pract Rheumatol 2006 : 2 : 252 261.
34. Mutlu S, Scully C. The person behind the eponym: Henrik Sjögren (1899-1986). J Oral Pathol Med 1993 : 22 : 439.
35. Navazesh M. Methods for collecting saliva. Ann N Y Acad Sci 1993 : 694 : 72 77.
36. Nieuw Amerongen AV, Veerman EC. Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies. Support Care Cancer 2003 : 11 : 226 231.
37. Ohbayashi N, Yamada I, Yoshino N, Sasaki T. Sjögren syndrome: comparison of assessments with MR sialography and conventional sialography. Radiology 1998 : 209 : 683 688.
38. Palmer RM, Eveson JW, Gusterson BA. Epimyoepithelial islands in lymphoepithelial lesions. An immunocytochemical study. Virchows Arch A Pathol Anat Histopathol 1986 : 408 : 603 609.
39. Petrone D, Condemi JJ, Fife R, Gluck O, Cohen S, Dalgin P. A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca. Arthritis Rheum 2002 : 46 : 748 754.
40. Pijpe J, Kalk WW, van der Wal JE, Vissink A, Kluin PM, Roodenburg JL, Bootsma H, Kallenberg CG, Spijkervet FK. Parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sjogren's syndrome. Rheumatology (Oxford) 2007 : 46 : 335 341.
41. Roberts BJ. Help for the dry mouth patient. J Dent 1982 : 10 : 226 234.
42. Scarantino C, LeVeque F, Swann RS, White R, Schulsinger A, Hodson DI, Meredith R, Foote R, Brachman D, Lee N. Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients. J Support Oncol 2006 : 4 : 252 258.
43. Scully C, Bagan JV. Adverse drug reactions in the orofacial region. Crit Rev Oral Biol Med 2004 : 15 : 221 239.
44. Strietzel FP, Martín-Granizo R, Fedele S, Lo Russo L, Mignogna M, Reichart PA, Wolff A, Wolff A. Electrostimulating device in the management of xerostomia. Oral Dis 2007 : 13 : 206 213.
45. Sugiura Y, Soga Y, Tanimoto I, Kokeguchi S, Nishide S, Kono K, Takahashi K, Fujii N, Ishimaru F, Tanimoto M, Yamabe K, Tsutani S, Nishimura F, Takashiba S. Antimicrobial effects of the saliva substitute, Oralbalance(R), against microorganisms from oral mucosa in the hematopoietic cell transplantation period. Support Care Cancer 2008 [Epub ahead of print].
46. Sweeney MP, Bagg J, Baxter WP, Aitchison TC. Clinical trial of a mucin-containing oral spray for treatment of xerostomia in hospice patients. Palliat Med 1997 : 11 : 225 232.
47. Takashima S, Takeuchi N, Morimoto S, Tomiyama N, Ikezoe J, Shogen K, Kozuka T, Okumura T. MR imaging of Sjögren syndrome: correlation with sialography and pathology. J Comput Assist Tomogr 1991 : 15 : 393 400.
48. Taweechaisupapong S, Pesee M, Aromdee C, Laopaiboon M, Khunkitti W. Efficacy of pilocarpine lozenge for post-radiation xerostomia in patients with head and neck cancer. Aust Dent J 2006 : 51 : 333 337.
49. Teppo H, Revonta M. A follow-up study of minimally invasive lip biopsy in the diagnosis of Sjögren's syndrome. Clin Rheumatol 2007 : 26 : 1099 1103.
50. Tonami H, Higashi K, Matoba M, Yokota H, Yamamoto I, Sugai S. A comparative study between MR sialography and salivary gland scintigraphy in the diagnosis of Sjögren syndrome. J Comput Assist Tomogr 2001 : 25 : 262 268.
51. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH, European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002 : 61 : 554 558.
52. Vitali C, Moutsopoulos HM, Bombardieri S. The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome. Ann Rheum Dis 1994 : 53 : 637 647.
53. Wall GC, Magarity ML, Jundt JW. Pharmacotherapy of xerostomia in primary Sjögren's syndrome. Pharmacotherapy 2002 : 22 : 621 629.
54. Warde P, Kroll B, O'Sullivan B, Aslanidis J, Tew-George E, Waldron J, Maxymiw W, Liu FF, Payne D, Cummings B. A phase II study of biotene in the treatment of postradiation xerostomia in patients with head and neck cancer. Support Care Cancer 2000 : 8 : 203 208.
55. Watanabe S, Dawes C. The effects of different foods and concentrations of citric acid on the flow rate of whole saliva in man. Arch Oral Biol 1988 : 33 : 1 5.
56. Watanabe S, Ohnishi M, Imai K, Kawano E, Igarashi S. Estimation of the total saliva volume produced per day in five-year-old children. Arch Oral Biol 1995 : 40 : 781 782.
57. Whaites E. Essentials of Dental Radiography and Radiology, 4th edn. Edinburgh : Churchill Livingstone, 2007 : 448.